nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP3A4—bone cancer	0.584	1	CbGaD
Mirtazapine—Azatadine—CYP3A4—bone cancer	0.00156	0.523	CrCbGaD
Mirtazapine—Epinastine—CYP3A4—bone cancer	0.0009	0.302	CrCbGaD
Mirtazapine—Mianserin—CYP3A4—bone cancer	0.000521	0.175	CrCbGaD
Mirtazapine—Neutropenia—Doxorubicin—bone cancer	0.000323	0.00106	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—bone cancer	0.000323	0.00106	CcSEcCtD
Mirtazapine—Hepatitis—Methotrexate—bone cancer	0.00032	0.00105	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—bone cancer	0.000319	0.00105	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—bone cancer	0.000319	0.00105	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—bone cancer	0.000318	0.00104	CcSEcCtD
Mirtazapine—Pharyngitis—Methotrexate—bone cancer	0.000317	0.00104	CcSEcCtD
Mirtazapine—Urinary tract disorder—Methotrexate—bone cancer	0.000316	0.00104	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000316	0.00104	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—bone cancer	0.000315	0.00104	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—bone cancer	0.000315	0.00103	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—bone cancer	0.000314	0.00103	CcSEcCtD
Mirtazapine—Urethral disorder—Methotrexate—bone cancer	0.000313	0.00103	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—bone cancer	0.000313	0.00103	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—bone cancer	0.000313	0.00103	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—bone cancer	0.000311	0.00102	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—bone cancer	0.00031	0.00102	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—bone cancer	0.000308	0.00101	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000306	0.001	CcSEcCtD
Mirtazapine—Hypersensitivity—Cisplatin—bone cancer	0.000305	0.001	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—bone cancer	0.000305	0.001	CcSEcCtD
Mirtazapine—Erythema multiforme—Methotrexate—bone cancer	0.000302	0.000993	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—bone cancer	0.000301	0.000988	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—bone cancer	0.000301	0.000988	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—bone cancer	0.0003	0.000986	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—bone cancer	0.0003	0.000985	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—bone cancer	0.0003	0.000985	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—bone cancer	0.000299	0.000983	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—bone cancer	0.000299	0.000982	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—bone cancer	0.000298	0.00098	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—bone cancer	0.000298	0.000978	CcSEcCtD
Mirtazapine—Asthenia—Cisplatin—bone cancer	0.000297	0.000976	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—bone cancer	0.000297	0.000976	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—bone cancer	0.000297	0.000975	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—bone cancer	0.000296	0.000972	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—bone cancer	0.000295	0.000971	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—bone cancer	0.000295	0.000969	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—bone cancer	0.000294	0.000966	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—bone cancer	0.000293	0.000964	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000292	0.000959	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—bone cancer	0.000291	0.000956	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—bone cancer	0.00029	0.000953	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—bone cancer	0.000289	0.000951	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—bone cancer	0.000288	0.000946	CcSEcCtD
Mirtazapine—Chills—Methotrexate—bone cancer	0.000287	0.000943	CcSEcCtD
Mirtazapine—Diarrhoea—Cisplatin—bone cancer	0.000283	0.000931	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—bone cancer	0.000283	0.00093	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—bone cancer	0.000282	0.000929	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—bone cancer	0.000282	0.000926	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—bone cancer	0.00028	0.000921	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—bone cancer	0.00028	0.000919	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—bone cancer	0.000279	0.000917	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—bone cancer	0.000278	0.000915	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—bone cancer	0.000278	0.000913	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—bone cancer	0.000277	0.000912	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—bone cancer	0.000277	0.00091	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—bone cancer	0.000275	0.000905	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—bone cancer	0.000275	0.000903	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—bone cancer	0.000273	0.000899	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—bone cancer	0.000273	0.000896	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—bone cancer	0.000272	0.000896	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—bone cancer	0.000271	0.000892	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—bone cancer	0.000271	0.000892	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—bone cancer	0.000269	0.000885	CcSEcCtD
Mirtazapine—Chills—Epirubicin—bone cancer	0.000268	0.000882	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—bone cancer	0.000267	0.000878	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—bone cancer	0.000264	0.000869	CcSEcCtD
Mirtazapine—Vomiting—Cisplatin—bone cancer	0.000263	0.000865	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—bone cancer	0.000262	0.000861	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—bone cancer	0.000262	0.00086	CcSEcCtD
Mirtazapine—Rash—Cisplatin—bone cancer	0.000261	0.000858	CcSEcCtD
Mirtazapine—Dermatitis—Cisplatin—bone cancer	0.000261	0.000857	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—bone cancer	0.00026	0.000856	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—bone cancer	0.000259	0.00085	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—bone cancer	0.000258	0.000849	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—bone cancer	0.000258	0.000848	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—bone cancer	0.000257	0.000845	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—bone cancer	0.000257	0.000844	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—bone cancer	0.000257	0.000843	CcSEcCtD
Mirtazapine—Tension—Epirubicin—bone cancer	0.000256	0.00084	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—bone cancer	0.000255	0.000838	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—bone cancer	0.000253	0.000831	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—bone cancer	0.000252	0.000828	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—bone cancer	0.000251	0.000825	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—bone cancer	0.000251	0.000825	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—bone cancer	0.00025	0.000822	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—bone cancer	0.000249	0.000819	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—bone cancer	0.000248	0.000816	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—bone cancer	0.000247	0.000813	CcSEcCtD
Mirtazapine—Nausea—Cisplatin—bone cancer	0.000246	0.000808	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—bone cancer	0.000245	0.000804	CcSEcCtD
Mirtazapine—Cough—Methotrexate—bone cancer	0.000243	0.000798	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—bone cancer	0.000242	0.000797	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—bone cancer	0.000242	0.000794	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—bone cancer	0.000241	0.000793	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—bone cancer	0.000241	0.000792	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—bone cancer	0.000241	0.000791	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—bone cancer	0.000239	0.000787	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—bone cancer	0.000237	0.00078	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—bone cancer	0.000237	0.000779	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—bone cancer	0.000237	0.000779	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—bone cancer	0.000237	0.000779	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—bone cancer	0.000236	0.000777	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—bone cancer	0.000236	0.000776	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000235	0.000773	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—bone cancer	0.000235	0.000772	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—bone cancer	0.000234	0.000769	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—bone cancer	0.000234	0.000769	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—bone cancer	0.000234	0.000769	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—bone cancer	0.000234	0.000768	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—bone cancer	0.000233	0.000766	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—bone cancer	0.000233	0.000766	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—bone cancer	0.00023	0.000756	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—bone cancer	0.000229	0.000753	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—bone cancer	0.000229	0.000752	CcSEcCtD
Mirtazapine—Cough—Epirubicin—bone cancer	0.000227	0.000747	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—bone cancer	0.000226	0.000742	CcSEcCtD
Mirtazapine—Infection—Methotrexate—bone cancer	0.000226	0.000742	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—bone cancer	0.000225	0.000739	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—bone cancer	0.000224	0.000735	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—bone cancer	0.000223	0.000732	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—bone cancer	0.000223	0.000732	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—bone cancer	0.000222	0.000731	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—bone cancer	0.000222	0.000729	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—bone cancer	0.000222	0.000729	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—bone cancer	0.000222	0.000729	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—bone cancer	0.000221	0.000728	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—bone cancer	0.000221	0.000726	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—bone cancer	0.000221	0.000725	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00022	0.000724	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—bone cancer	0.00022	0.000722	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—bone cancer	0.000219	0.00072	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—bone cancer	0.000217	0.000714	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—bone cancer	0.000217	0.000713	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—bone cancer	0.000216	0.000712	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—bone cancer	0.000216	0.000712	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—bone cancer	0.000216	0.00071	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—bone cancer	0.000216	0.000709	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—bone cancer	0.000214	0.000704	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—bone cancer	0.000213	0.0007	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—bone cancer	0.000213	0.000699	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—bone cancer	0.000212	0.000698	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—bone cancer	0.000212	0.000696	CcSEcCtD
Mirtazapine—Infection—Epirubicin—bone cancer	0.000211	0.000694	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—bone cancer	0.00021	0.000691	CcSEcCtD
Mirtazapine—Shock—Epirubicin—bone cancer	0.000209	0.000687	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—bone cancer	0.000209	0.000686	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—bone cancer	0.000208	0.000685	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—bone cancer	0.000208	0.000684	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—bone cancer	0.000208	0.000684	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—bone cancer	0.000207	0.000682	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000207	0.00068	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—bone cancer	0.000206	0.000679	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—bone cancer	0.000205	0.000675	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—bone cancer	0.000205	0.000675	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—bone cancer	0.000205	0.000674	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—bone cancer	0.000205	0.000674	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—bone cancer	0.000205	0.000674	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—bone cancer	0.000204	0.000672	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—bone cancer	0.000204	0.00067	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000204	0.00067	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—bone cancer	0.000203	0.000666	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—bone cancer	0.000203	0.000666	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—bone cancer	0.000202	0.000666	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—bone cancer	0.000202	0.000664	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—bone cancer	0.000201	0.000659	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—bone cancer	0.0002	0.000657	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—bone cancer	0.000199	0.000653	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—bone cancer	0.000198	0.000652	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—bone cancer	0.000197	0.000649	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—bone cancer	0.000197	0.000646	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000196	0.000644	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—bone cancer	0.000196	0.000644	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—bone cancer	0.000195	0.000642	CcSEcCtD
Mirtazapine—Pain—Methotrexate—bone cancer	0.000194	0.000638	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000194	0.000636	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—bone cancer	0.000193	0.000636	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—bone cancer	0.000193	0.000634	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—bone cancer	0.000193	0.000633	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—bone cancer	0.000192	0.000632	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—bone cancer	0.000192	0.000631	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—bone cancer	0.000191	0.000628	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—bone cancer	0.000191	0.000627	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—bone cancer	0.00019	0.000625	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—bone cancer	0.000189	0.000623	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—bone cancer	0.000189	0.000621	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—bone cancer	0.000187	0.000616	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—bone cancer	0.000187	0.000615	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—bone cancer	0.000187	0.000615	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—bone cancer	0.000186	0.00061	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—bone cancer	0.000185	0.000607	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—bone cancer	0.000184	0.000604	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000183	0.000603	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—bone cancer	0.000183	0.000602	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—bone cancer	0.000182	0.000597	CcSEcCtD
Mirtazapine—Pain—Epirubicin—bone cancer	0.000182	0.000597	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—bone cancer	0.00018	0.000593	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—bone cancer	0.00018	0.00059	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—bone cancer	0.00018	0.00059	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000179	0.000589	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—bone cancer	0.000178	0.000585	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—bone cancer	0.000177	0.00058	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—bone cancer	0.000175	0.000576	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—bone cancer	0.000175	0.000576	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—bone cancer	0.000175	0.000575	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—bone cancer	0.000174	0.000571	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—bone cancer	0.000173	0.000569	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—bone cancer	0.000171	0.000562	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00017	0.000558	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—bone cancer	0.00017	0.000557	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—bone cancer	0.000169	0.000555	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—bone cancer	0.000168	0.000553	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—bone cancer	0.000168	0.000553	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—bone cancer	0.000168	0.000552	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—bone cancer	0.000168	0.000552	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—bone cancer	0.000167	0.00055	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—bone cancer	0.000163	0.000536	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—bone cancer	0.000162	0.000533	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000161	0.000529	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—bone cancer	0.000161	0.000528	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—bone cancer	0.000157	0.000515	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—bone cancer	0.000156	0.000514	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—bone cancer	0.000155	0.000511	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—bone cancer	0.000155	0.000511	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—bone cancer	0.000155	0.000511	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—bone cancer	0.000152	0.000501	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—bone cancer	0.00015	0.000494	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—bone cancer	0.00015	0.000494	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—bone cancer	0.000145	0.000478	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—bone cancer	0.000145	0.000476	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—bone cancer	0.000144	0.000475	CcSEcCtD
Mirtazapine—Rash—Methotrexate—bone cancer	0.000143	0.000471	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—bone cancer	0.000143	0.00047	CcSEcCtD
Mirtazapine—Headache—Methotrexate—bone cancer	0.000142	0.000468	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—bone cancer	0.000141	0.000464	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—bone cancer	0.000141	0.000462	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—bone cancer	0.000139	0.000457	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—bone cancer	0.000135	0.000444	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—bone cancer	0.000135	0.000443	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—bone cancer	0.000135	0.000442	CcSEcCtD
Mirtazapine—Rash—Epirubicin—bone cancer	0.000134	0.00044	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—bone cancer	0.000134	0.00044	CcSEcCtD
Mirtazapine—Headache—Epirubicin—bone cancer	0.000133	0.000438	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—bone cancer	0.00013	0.000427	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—bone cancer	0.000126	0.000415	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—bone cancer	0.000125	0.000411	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—bone cancer	0.000124	0.000408	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—bone cancer	0.000124	0.000407	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—bone cancer	0.000123	0.000405	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—bone cancer	0.000117	0.000384	CcSEcCtD
Mirtazapine—HTR7—Signaling Pathways—IL3—bone cancer	3.74e-05	0.000344	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—GRM1—bone cancer	3.73e-05	0.000343	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL3—bone cancer	3.69e-05	0.000339	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—ATF1—bone cancer	3.67e-05	0.000338	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL3—bone cancer	3.58e-05	0.000329	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—GNA11—bone cancer	3.54e-05	0.000325	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—GNA11—bone cancer	3.51e-05	0.000322	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—ATF1—bone cancer	3.51e-05	0.000322	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SMO—bone cancer	3.5e-05	0.000321	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SMO—bone cancer	3.42e-05	0.000314	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL3—bone cancer	3.42e-05	0.000314	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SMO—bone cancer	3.34e-05	0.000307	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SMO—bone cancer	3.33e-05	0.000306	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—MDM2—bone cancer	3.33e-05	0.000306	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ENO2—bone cancer	3.32e-05	0.000305	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ATF1—bone cancer	3.26e-05	0.0003	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TGFBR2—bone cancer	3.25e-05	0.000299	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SMO—bone cancer	3.24e-05	0.000297	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NT5C3A—bone cancer	3.22e-05	0.000296	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—CYP3A4—bone cancer	3.21e-05	0.000295	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TGFBR2—bone cancer	3.2e-05	0.000294	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—GNA11—bone cancer	3.2e-05	0.000294	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL3—bone cancer	3.18e-05	0.000292	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—GNA11—bone cancer	3.13e-05	0.000287	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—DHFR—bone cancer	3.08e-05	0.000283	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFBR2—bone cancer	3.06e-05	0.000282	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—GNA11—bone cancer	3.06e-05	0.000281	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IGF1R—bone cancer	3.06e-05	0.000281	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—GNA11—bone cancer	3.04e-05	0.00028	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IGF1R—bone cancer	3.01e-05	0.000277	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ATF1—bone cancer	2.97e-05	0.000273	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—GNA11—bone cancer	2.96e-05	0.000272	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SMO—bone cancer	2.94e-05	0.00027	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.92e-05	0.000269	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ATF1—bone cancer	2.91e-05	0.000267	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL3—bone cancer	2.9e-05	0.000266	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—JUN—bone cancer	2.89e-05	0.000266	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SMO—bone cancer	2.89e-05	0.000265	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SMO—bone cancer	2.88e-05	0.000265	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IGF1R—bone cancer	2.88e-05	0.000265	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—GNA11—bone cancer	2.87e-05	0.000264	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ATF1—bone cancer	2.84e-05	0.000261	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL3—bone cancer	2.84e-05	0.000261	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ATF1—bone cancer	2.83e-05	0.00026	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SMO—bone cancer	2.83e-05	0.00026	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—MMP9—bone cancer	2.81e-05	0.000258	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL3—bone cancer	2.77e-05	0.000255	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL3—bone cancer	2.76e-05	0.000253	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ATF1—bone cancer	2.75e-05	0.000253	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.75e-05	0.000253	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—GSTP1—bone cancer	2.74e-05	0.000252	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.72e-05	0.00025	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—GNA11—bone cancer	2.69e-05	0.000247	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL3—bone cancer	2.68e-05	0.000247	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—GNA11—bone cancer	2.64e-05	0.000243	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—GNA11—bone cancer	2.64e-05	0.000242	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ENO2—bone cancer	2.63e-05	0.000242	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SMO—bone cancer	2.63e-05	0.000242	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CYP3A4—bone cancer	2.61e-05	0.00024	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.59e-05	0.000238	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IGF1R—bone cancer	2.56e-05	0.000235	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ATF1—bone cancer	2.5e-05	0.000229	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFBR2—bone cancer	2.48e-05	0.000228	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ATF1—bone cancer	2.46e-05	0.000226	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ATF1—bone cancer	2.45e-05	0.000225	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—DHFR—bone cancer	2.44e-05	0.000224	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL3—bone cancer	2.43e-05	0.000224	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFBR2—bone cancer	2.43e-05	0.000223	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.41e-05	0.000221	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.4e-05	0.000221	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL3—bone cancer	2.4e-05	0.00022	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL3—bone cancer	2.39e-05	0.00022	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.37e-05	0.000218	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.36e-05	0.000217	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL3—bone cancer	2.35e-05	0.000216	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IGF1R—bone cancer	2.33e-05	0.000214	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.29e-05	0.000211	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—GNA11—bone cancer	2.28e-05	0.00021	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IGF1R—bone cancer	2.28e-05	0.00021	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—EGFR—bone cancer	2.27e-05	0.000209	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.23e-05	0.000205	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.23e-05	0.000205	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—GSTP1—bone cancer	2.23e-05	0.000205	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.22e-05	0.000204	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KIT—bone cancer	2.22e-05	0.000204	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KIT—bone cancer	2.18e-05	0.000201	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL3—bone cancer	2.18e-05	0.0002	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ENO2—bone cancer	2.16e-05	0.000199	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IGF1R—bone cancer	2.16e-05	0.000198	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ENO2—bone cancer	2.14e-05	0.000197	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KIT—bone cancer	2.09e-05	0.000192	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—TP53—bone cancer	2.09e-05	0.000192	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—BRAF—bone cancer	2.09e-05	0.000192	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.08e-05	0.000191	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CYP3A4—bone cancer	2.07e-05	0.00019	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.06e-05	0.000189	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—BRAF—bone cancer	2.05e-05	0.000189	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.05e-05	0.000188	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.04e-05	0.000188	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—EGFR—bone cancer	2.02e-05	0.000186	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.01e-05	0.000184	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—DHFR—bone cancer	2e-05	0.000184	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KIT—bone cancer	2e-05	0.000183	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—EGFR—bone cancer	1.99e-05	0.000183	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—DHFR—bone cancer	1.99e-05	0.000183	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—BRAF—bone cancer	1.96e-05	0.000181	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.96e-05	0.00018	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.93e-05	0.000177	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IGF1R—bone cancer	1.92e-05	0.000177	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TP53—bone cancer	1.91e-05	0.000175	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—EGFR—bone cancer	1.9e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.89e-05	0.000173	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—BRAF—bone cancer	1.88e-05	0.000172	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GNA11—bone cancer	1.87e-05	0.000172	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.86e-05	0.000171	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GNA11—bone cancer	1.86e-05	0.000171	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KIT—bone cancer	1.86e-05	0.000171	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ENO2—bone cancer	1.83e-05	0.000168	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.82e-05	0.000167	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—GSTP1—bone cancer	1.77e-05	0.000163	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.75e-05	0.000161	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MDM2—bone cancer	1.75e-05	0.000161	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—BRAF—bone cancer	1.75e-05	0.00016	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MDM2—bone cancer	1.72e-05	0.000158	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.7e-05	0.000156	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—DHFR—bone cancer	1.7e-05	0.000156	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—bone cancer	1.7e-05	0.000156	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KIT—bone cancer	1.69e-05	0.000155	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—EGFR—bone cancer	1.69e-05	0.000155	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000155	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.68e-05	0.000154	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KIT—bone cancer	1.65e-05	0.000152	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MDM2—bone cancer	1.65e-05	0.000151	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KIT—bone cancer	1.62e-05	0.000149	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KIT—bone cancer	1.61e-05	0.000148	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—BRAF—bone cancer	1.59e-05	0.000146	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GNA11—bone cancer	1.59e-05	0.000146	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KIT—bone cancer	1.57e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—BRAF—bone cancer	1.56e-05	0.000143	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—EGFR—bone cancer	1.54e-05	0.000142	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.52e-05	0.00014	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—JUN—bone cancer	1.52e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.51e-05	0.000139	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—EGFR—bone cancer	1.51e-05	0.000139	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—JUN—bone cancer	1.49e-05	0.000137	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MMP9—bone cancer	1.48e-05	0.000136	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.47e-05	0.000135	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.47e-05	0.000135	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.47e-05	0.000135	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MDM2—bone cancer	1.46e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MMP9—bone cancer	1.45e-05	0.000134	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GSTP1—bone cancer	1.45e-05	0.000133	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GSTP1—bone cancer	1.44e-05	0.000132	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.44e-05	0.000132	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.43e-05	0.000132	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—JUN—bone cancer	1.43e-05	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.43e-05	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—bone cancer	1.42e-05	0.000131	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KIT—bone cancer	1.42e-05	0.000131	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ENO2—bone cancer	1.41e-05	0.00013	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KIT—bone cancer	1.4e-05	0.000128	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KIT—bone cancer	1.39e-05	0.000128	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MMP9—bone cancer	1.39e-05	0.000128	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.37e-05	0.000126	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—JUN—bone cancer	1.37e-05	0.000126	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—BRAF—bone cancer	1.34e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MDM2—bone cancer	1.33e-05	0.000122	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MMP9—bone cancer	1.33e-05	0.000122	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.31e-05	0.000121	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—BRAF—bone cancer	1.31e-05	0.00012	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—DHFR—bone cancer	1.31e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MDM2—bone cancer	1.3e-05	0.00012	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.29e-05	0.000119	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.29e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—JUN—bone cancer	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.25e-05	0.000115	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MMP9—bone cancer	1.24e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.23e-05	0.000113	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTP1—bone cancer	1.23e-05	0.000113	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GNA11—bone cancer	1.22e-05	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.2e-05	0.00011	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—bone cancer	1.19e-05	0.00011	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—bone cancer	1.18e-05	0.000108	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.16e-05	0.000106	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—JUN—bone cancer	1.16e-05	0.000106	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—bone cancer	1.15e-05	0.000106	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—JUN—bone cancer	1.13e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—bone cancer	1.13e-05	0.000104	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—bone cancer	1.13e-05	0.000103	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MDM2—bone cancer	1.12e-05	0.000103	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—JUN—bone cancer	1.11e-05	0.000102	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—bone cancer	1.1e-05	0.000101	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—JUN—bone cancer	1.1e-05	0.000101	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.1e-05	0.000101	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MDM2—bone cancer	1.1e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.08e-05	9.91e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.08e-05	9.9e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—bone cancer	1.07e-05	9.87e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.07e-05	9.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—JUN—bone cancer	1.07e-05	9.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.04e-05	9.58e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—bone cancer	1e-05	9.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1e-05	9.2e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—bone cancer	9.99e-06	9.18e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—bone cancer	9.87e-06	9.07e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JUN—bone cancer	9.73e-06	8.94e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—bone cancer	9.57e-06	8.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—bone cancer	9.55e-06	8.78e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—bone cancer	9.5e-06	8.73e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—bone cancer	9.46e-06	8.7e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—bone cancer	9.45e-06	8.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—bone cancer	9.37e-06	8.61e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—bone cancer	9.31e-06	8.56e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—bone cancer	9.29e-06	8.54e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—bone cancer	9.17e-06	8.42e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—bone cancer	9.12e-06	8.38e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—bone cancer	9.11e-06	8.37e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—bone cancer	9.02e-06	8.29e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—bone cancer	8.91e-06	8.18e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—bone cancer	8.71e-06	8e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—bone cancer	8.71e-06	8e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—bone cancer	8.66e-06	7.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—bone cancer	8.47e-06	7.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—bone cancer	8.43e-06	7.74e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—bone cancer	8.39e-06	7.71e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—bone cancer	7.65e-06	7.03e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—bone cancer	7.65e-06	7.03e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—bone cancer	7.53e-06	6.92e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—bone cancer	7.52e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—bone cancer	7.51e-06	6.9e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—bone cancer	7.48e-06	6.87e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—bone cancer	7.46e-06	6.86e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—bone cancer	7.37e-06	6.77e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—bone cancer	7.31e-06	6.72e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—bone cancer	7.27e-06	6.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—bone cancer	7.08e-06	6.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—bone cancer	6.85e-06	6.29e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—bone cancer	6.42e-06	5.9e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—bone cancer	6.38e-06	5.86e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—bone cancer	6.32e-06	5.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—bone cancer	6.3e-06	5.79e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—bone cancer	6.19e-06	5.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—bone cancer	5.75e-06	5.28e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—bone cancer	4.92e-06	4.52e-05	CbGpPWpGaD
